Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Minoru Fukuda

Showing results (211-220 of 254) with videos related to

Pageof 26
Sort By:
Thoracic Cancer|May 29, 2020
Amrubicin in previously treated patients with malignant pleural mesothelioma: A phase II studyTakaya Ikeda, Shinnosuke Takemoto, Hiroaki Senju, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|November 1, 2020
[Trends in Outpatient Chemotherapy for Thoracic Oncology]Minoru Fukuda, Hiroyuki Yamaguchi, Shinnosuke Takemoto, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|June 6, 2019
[Efforts toward Venous Access of Anti-Cancer Drug by Nurses]Kazue Suzuki, Akemi Tsuchiya, Erika Nakamura, et al.
Thoracic Cancer|January 11, 2019
Phase II trial of a non-platinum triplet for patients with advanced non-small cell lung carcinoma (NSCLC) overexpressing ERCC1 messenger RNAShinnosuke Takemoto, Yoichi Nakamura, Hiroshi Gyoutoku, et al.
The Journal of Clinical Investigation|February 7, 2012
Essential role of gastric gland mucin in preventing gastric cancer in miceFumitoshi Karasawa, Akira Shiota, Yukinobu Goso, et al.
Thoracic Cancer|November 20, 2020
Dabrafenib and trametinib therapy in an elderly patient with non-small cell lung cancer harboring the BRAF V600E mutationYosuke Dotsu, Minoru Fukuda, Noritaka Honda, et al.
Cancer Chemotherapy and Pharmacology|September 6, 2019
Dose escalation study of amrubicin and cisplatin with concurrent thoracic radiotherapy for limited-disease small cell lung cancerMidori Shimada, Hiroyuki Yamaguchi, Minoru Fukuda, et al.
The EMBO Journal|June 30, 2011
A novel strategy for evasion of NK cell immunity by tumours expressing core2 O-glycansShigeru Tsuboi, Mihoko Sutoh, Shingo Hatakeyama, et al.
Cancer Chemotherapy and Pharmacology|July 19, 2014
A phase II study of amrubicin and carboplatin for previously untreated patients with extensive-disease small cell lung cancerTakaya Ikeda, Minoru Fukuda, Yoichi Nakamura, et al.
Lung Cancer Management|June 7, 2023
Proportion of biopsy specimens containing a tumor when compared to all biopsy specimens by transbronchial biopsyShinnosuke Takemoto, Mutsumi Ozasa, Remi Mizuta, et al.
Pageof 26

Showing results (211-220 of 254) with videos related to

Sort By:
Pageof 26
Thoracic Cancer|May 29, 2020
Amrubicin in previously treated patients with malignant pleural mesothelioma: A phase II studyTakaya Ikeda, Shinnosuke Takemoto, Hiroaki Senju, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|November 1, 2020
[Trends in Outpatient Chemotherapy for Thoracic Oncology]Minoru Fukuda, Hiroyuki Yamaguchi, Shinnosuke Takemoto, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|June 6, 2019
[Efforts toward Venous Access of Anti-Cancer Drug by Nurses]Kazue Suzuki, Akemi Tsuchiya, Erika Nakamura, et al.
Thoracic Cancer|January 11, 2019
Phase II trial of a non-platinum triplet for patients with advanced non-small cell lung carcinoma (NSCLC) overexpressing ERCC1 messenger RNAShinnosuke Takemoto, Yoichi Nakamura, Hiroshi Gyoutoku, et al.
The Journal of Clinical Investigation|February 7, 2012
Essential role of gastric gland mucin in preventing gastric cancer in miceFumitoshi Karasawa, Akira Shiota, Yukinobu Goso, et al.
Thoracic Cancer|November 20, 2020
Dabrafenib and trametinib therapy in an elderly patient with non-small cell lung cancer harboring the BRAF V600E mutationYosuke Dotsu, Minoru Fukuda, Noritaka Honda, et al.
Cancer Chemotherapy and Pharmacology|September 6, 2019
Dose escalation study of amrubicin and cisplatin with concurrent thoracic radiotherapy for limited-disease small cell lung cancerMidori Shimada, Hiroyuki Yamaguchi, Minoru Fukuda, et al.
The EMBO Journal|June 30, 2011
A novel strategy for evasion of NK cell immunity by tumours expressing core2 O-glycansShigeru Tsuboi, Mihoko Sutoh, Shingo Hatakeyama, et al.
Cancer Chemotherapy and Pharmacology|July 19, 2014
A phase II study of amrubicin and carboplatin for previously untreated patients with extensive-disease small cell lung cancerTakaya Ikeda, Minoru Fukuda, Yoichi Nakamura, et al.
Lung Cancer Management|June 7, 2023
Proportion of biopsy specimens containing a tumor when compared to all biopsy specimens by transbronchial biopsyShinnosuke Takemoto, Mutsumi Ozasa, Remi Mizuta, et al.
Pageof 26